PortfoliosLab logoPortfoliosLab logo
SAUHY vs. AZN
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SAUHY vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Straumann Holding AG ADR (SAUHY) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SAUHY vs. AZN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SAUHY
Straumann Holding AG ADR
-9.79%-5.91%-22.01%43.22%5.25%79.03%21.76%58.49%-10.24%8.83%
AZN
AstraZeneca PLC
11.46%43.30%-0.62%1.44%19.14%19.66%3.12%35.68%13.86%2.06%

Fundamentals

Market Cap

SAUHY:

$16.64B

AZN:

$313.54B

EPS

SAUHY:

$0.47

AZN:

$6.55

PE Ratio

SAUHY:

22.47

AZN:

30.64

PEG Ratio

SAUHY:

8.13

AZN:

0.04

PS Ratio

SAUHY:

3.28

AZN:

5.33

PB Ratio

SAUHY:

7.70

AZN:

6.44

Total Revenue (TTM)

SAUHY:

$5.10B

AZN:

$58.74B

Gross Profit (TTM)

SAUHY:

$3.57B

AZN:

$48.11B

EBITDA (TTM)

SAUHY:

$1.97B

AZN:

$19.83B

Returns By Period

In the year-to-date period, SAUHY achieves a -9.79% return, which is significantly lower than AZN's 11.46% return.


SAUHY

1D
1.84%
1M
-8.21%
YTD
-9.79%
6M
-3.13%
1Y
-12.22%
3Y*
-10.32%
5Y*
10.07%
10Y*

AZN

1D
1.78%
1M
-1.47%
YTD
11.46%
6M
21.46%
1Y
42.12%
3Y*
15.74%
5Y*
17.86%
10Y*
16.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SAUHY vs. AZN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SAUHY
SAUHY Risk / Return Rank: 2525
Overall Rank
SAUHY Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
SAUHY Sortino Ratio Rank: 2323
Sortino Ratio Rank
SAUHY Omega Ratio Rank: 2323
Omega Ratio Rank
SAUHY Calmar Ratio Rank: 2828
Calmar Ratio Rank
SAUHY Martin Ratio Rank: 2525
Martin Ratio Rank

AZN
AZN Risk / Return Rank: 8484
Overall Rank
AZN Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
AZN Sortino Ratio Rank: 8282
Sortino Ratio Rank
AZN Omega Ratio Rank: 8080
Omega Ratio Rank
AZN Calmar Ratio Rank: 8787
Calmar Ratio Rank
AZN Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SAUHY vs. AZN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Straumann Holding AG ADR (SAUHY) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SAUHYAZNDifference

Sharpe ratio

Return per unit of total volatility

-0.34

1.56

-1.90

Sortino ratio

Return per unit of downside risk

-0.27

2.25

-2.53

Omega ratio

Gain probability vs. loss probability

0.97

1.29

-0.32

Calmar ratio

Return relative to maximum drawdown

-0.39

3.25

-3.64

Martin ratio

Return relative to average drawdown

-0.89

8.16

-9.05

SAUHY vs. AZN - Sharpe Ratio Comparison

The current SAUHY Sharpe Ratio is -0.34, which is lower than the AZN Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of SAUHY and AZN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SAUHYAZNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.34

1.56

-1.90

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.16

0.75

-0.59

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.68

Sharpe Ratio (All Time)

Calculated using the full available price history

0.29

0.51

-0.22

Correlation

The correlation between SAUHY and AZN is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SAUHY vs. AZN - Dividend Comparison

SAUHY's dividend yield for the trailing twelve months is around 0.62%, less than AZN's 2.65% yield.


TTM20252024202320222021202020192018201720162015
SAUHY
Straumann Holding AG ADR
0.62%0.56%1.06%0.54%0.32%0.28%0.28%0.30%0.00%0.00%0.00%0.00%
AZN
AstraZeneca PLC
2.65%1.70%2.27%2.15%2.12%2.35%2.80%2.81%3.69%3.95%5.01%4.06%

Drawdowns

SAUHY vs. AZN - Drawdown Comparison

The maximum SAUHY drawdown since its inception was -49.95%, roughly equal to the maximum AZN drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for SAUHY and AZN.


Loading graphics...

Drawdown Indicators


SAUHYAZNDifference

Max Drawdown

Largest peak-to-trough decline

-49.95%

-48.94%

-1.01%

Max Drawdown (1Y)

Largest decline over 1 year

-31.50%

-12.24%

-19.26%

Max Drawdown (5Y)

Largest decline over 5 years

-49.95%

-27.87%

-22.08%

Max Drawdown (10Y)

Largest decline over 10 years

-27.87%

Current Drawdown

Current decline from peak

-37.58%

-3.70%

-33.88%

Average Drawdown

Average peak-to-trough decline

-13.69%

-11.38%

-2.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.71%

4.88%

+8.83%

Volatility

SAUHY vs. AZN - Volatility Comparison

Straumann Holding AG ADR (SAUHY) has a higher volatility of 10.88% compared to AstraZeneca PLC (AZN) at 7.15%. This indicates that SAUHY's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SAUHYAZNDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.88%

7.15%

+3.73%

Volatility (6M)

Calculated over the trailing 6-month period

23.52%

19.20%

+4.32%

Volatility (1Y)

Calculated over the trailing 1-year period

35.87%

27.33%

+8.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.68%

23.85%

+38.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.69%

24.90%

+29.79%

Financials

SAUHY vs. AZN - Financials Comparison

This section allows you to compare key financial metrics between Straumann Holding AG ADR and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
1.25B
15.50B
(SAUHY) Total Revenue
(AZN) Total Revenue
Values in USD except per share items

SAUHY vs. AZN - Profitability Comparison

The chart below illustrates the profitability comparison between Straumann Holding AG ADR and AstraZeneca PLC over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20212022202320242025
65.1%
79.9%
Portfolio components
SAUHY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Straumann Holding AG ADR reported a gross profit of 811.38M and revenue of 1.25B. Therefore, the gross margin over that period was 65.1%.

AZN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AstraZeneca PLC reported a gross profit of 12.39B and revenue of 15.50B. Therefore, the gross margin over that period was 79.9%.

SAUHY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Straumann Holding AG ADR reported an operating income of 811.38M and revenue of 1.25B, resulting in an operating margin of 65.1%.

AZN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AstraZeneca PLC reported an operating income of 2.98B and revenue of 15.50B, resulting in an operating margin of 19.2%.

SAUHY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Straumann Holding AG ADR reported a net income of 118.83M and revenue of 1.25B, resulting in a net margin of 9.5%.

AZN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AstraZeneca PLC reported a net income of 2.33B and revenue of 15.50B, resulting in a net margin of 15.0%.